BioLineRx Ltd. Logo

BioLineRx Ltd.

A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.

BLRX | TA

Overview

Corporate Details

ISIN(s):
US09071M2052 (+1 more)
LEI:
529900AKIOSC15Y63R18
Country:
Israel
Address:
Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in

Description

BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-05-17 17:57
Immediate Report
English 211.2 KB
2018-05-17 17:57
Immediate Report
English 39.4 KB
2018-05-16 15:58
Immediate Report
English 146.4 KB
2018-05-16 15:58
Immediate Report
English 39.4 KB
2018-04-24 15:58
Immediate Report
English 130.2 KB
2018-04-24 15:58
Immediate Report
English 39.3 KB
2018-04-16 17:58
Immediate Report
English 129.6 KB
2018-04-16 17:58
Immediate Report
English 39.4 KB
2018-03-26 15:58
Immediate Report
English 146.1 KB
2018-03-26 15:58
Immediate Report
English 39.4 KB
2018-03-12 13:57
Immediate Report of Meeting
English 64.7 KB
2018-03-12 13:57
Immediate Report of Meeting
English 106.3 KB
2018-03-12 13:57
Immediate Report of Meeting
English 130.5 KB
2018-03-06 14:59
Report of Periodic or Interim Report
English 1.1 MB
2018-03-06 14:59
Report of Periodic or Interim Report
English 39.3 KB

Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioLineRx Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celemics, Inc. Logo
Develops NGS target enrichment solutions for research and clinical applications.
South Korea
331920
Develops radiopharmaceuticals and radioligand therapies for oncology.
South Korea
308430
CELL BIOTECH CO ., LTD Logo
Develops and manufactures probiotic solutions using patented dual-coating technology.
South Korea
049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based immunotherapies for severe inflammatory and allergic diseases.
United States of America
CLDX
Cellectar Biosciences, Inc. Logo
Clinical-stage biopharma developing targeted cancer treatments via a PDC platform.
United States of America
CLRB
Cellectis Logo
Develops allogeneic, or 'off-the-shelf', CAR T-cell immunotherapies for cancer.
France
ALCLS
Cellid Co., Ltd. Logo
Develops immunotherapeutic vaccines for cancer and infectious diseases.
South Korea
299660
Cellromax Science Co., Ltd. Logo
Researches and develops health foods, derma-cosmetics, and OTC pharmaceuticals.
South Korea
471820
CellSeed Inc. Logo
Develops and commercializes cell sheet engineering for regenerative medicine.
Japan
7776
Celltrion, Inc. Logo
Biopharmaceutical firm developing biosimilars for autoimmune diseases and oncology.
South Korea
068270

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.